Shoulder Fracture Clinical Trial
Official title:
Effectiveness at 3 Months of Immediate Shoulder Mobilisation Versus Conventional Immobilisation for Impacted Nonsurgically Treated Proximal Humerus Fracture: a Randomised Controlled Trial.
Background: Nonsurgical proximal humerus fracture is common, causing prolonged disability, for which the time to begin rehabilitation is not well determined. We assessed the feasibility and efficacy of early (within 3 days’after fracture) mobilisation of the shoulder compared with conventional 3-week immobilization followed by physiotherapy.
Status | Terminated |
Enrollment | 76 |
Est. completion date | September 2005 |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 20 Years and older |
Eligibility |
Inclusion Criteria: - Impacted nonsurgically treated proximal humerus fracture - Patients over the age 20 Exclusion Criteria: - Pre-existing shoulder pathology - Neurological disorders of the upper limbs - Indication for surgery of the shoulder - Combined polytrauma - Difficulties with language or comprehension to understand a rehabilitation program and information |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
France | Hopital Cochin | Paris |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique - Hôpitaux de Paris |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The primary outcome was functional assessment of the shoulder (Constant score) at 3 months. | |||
Secondary | Functional assessment at 6 weeks and at 6 months | |||
Secondary | Change in pain (on a visual analogue scale)at 6 weeks, 3 months and at 6 months | |||
Secondary | Passive range of motion at 6 weeks, 3 months and at 6 months. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02182752 -
The Effect of Tramadol on Interscalene Brachial Plexus Block
|
Phase 2 |